Ptc Therapeutics reported $981.61M in Loan Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Alnylam Pharmaceuticals ALNY:US USD 1.02B 338.25M
Amgen AMGN:US USD 37.16B 1.46B
Biogen BIIB:US USD 6.28B 1.8M
Biomarin Pharmaceutical BMRN:US USD 1.08B 986K
Cytokinetics CYTK:US USD 609.73M 411.31M
Daiichi Sankyo 4568:JP JPY 101.88B 41.09B
Enanta Pharmaceuticals ENTA:US USD 1.42M 83K
Esperion Therapeutics ESPR:US USD 259.49M 407K
Intercept Pharmaceuticals ICPT:US USD 222.86M 491M
IONIS PHARMACEUT IONS:US USD 1.25B 1.1M
Ironwood Pharmaceuticals IRWD:US USD 395.85M 399K
Karyopharm Therapeutics KPTI:US USD 302.89M 201K
Novartis NOVN:VX USD 21.24B 2.55B
Ptc Therapeutics PTCT:US USD 981.61M 165K
Sarepta Therapeutics SRPT:US USD 1.54B 441.9M
Tg Therapeutics TGTX:US USD 70.04M 1.09M
Vertex Pharmaceuticals VRTX:US USD 442.3M 40M
YTE INCY:US USD 30.48M 681K